Development of Efficient Sodium Alginate/Polysuccinimide-Based Hydrogels as Biodegradable Acetaminophen Delivery
Long Toan Trinh1, Saebin Lim1, Hyun Jong Lee1
1Department of Chemical and Biological Engineering, Gachon University, Seongnam-si 13120, Republic of Korea.
Gels (Basel, Switzerland)
|December 22, 2023
Summary
This study developed novel sodium alginate/polysuccinimide (PSI) hydrogels for efficient acetaminophen (AP) delivery. These hydrogels enable once-daily dosing, improving patient outcomes by providing sustained AP release over 24 hours.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Oral acetaminophen (AP) requires frequent administration (approx. 4 times daily), posing risks of overdose and frequent use.
- Developing efficient drug delivery systems is crucial for enhancing patient outcomes and therapeutic efficacy.
- Biodegradable polymers offer potential for safer and more effective drug administration routes.
Purpose of the Study:
- To develop an efficient, once-daily drug delivery system for acetaminophen (AP).
- To create novel sodium alginate and polysuccinimide (PSI) hydrogels for sustained AP release.
- To evaluate the hydrogels' properties, including mechanical strength, drug dissolution, biodegradability, and release profiles.
Main Methods:
- Fabrication of sodium alginate/PSI hydrogels.
- Characterization of hydrogel mechanical properties.
- Assessment of drug dissolution and release kinetics.
- Evaluation of PSI biodegradability via intestinal hydrolysis.
Main Results:
- The developed hydrogels demonstrated improved structural mechanical properties.
- PSI hydrolysis in the intestine facilitated complete drug dissolution and elimination.
- The hydrogels provided a continuous release of AP over a 24-hour period.
- Sustained release profiles indicate potential for once-daily dosing.
Conclusions:
- Sodium alginate/PSI hydrogels show promise as biodegradable delivery systems for acetaminophen (AP).
- These hydrogels can potentially reduce dosing frequency and improve patient compliance.
- The findings have implications for developing advanced drug delivery systems for various therapeutic agents.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...


